22 WiSys Technologies in "Analytical Instrumentation" or "Information Technology" or "Pharmaceuticals & Vitamin D" or "Research Tools" or "Food & Supplements" or "Medical Imaging"
WiSys is seeking strategic partners interested in the commercial use of this innovation.
Researchers from the University of Wisconsin - Stevens Point are part of a multi-institution research team that has developed a vaccine with proven efficacy in preventing Francisella infections in fish.
WiSys is seeking strategic partners interested in the commercial use of this innovation
WiSys is seeking a strategic partner skilled in the manufacturing and distribution of insulated storage containers or portable mini refrigerators. Ideally, this partner could provide a route to market for the commercialization and use of this retrofit Peltier cooling device.
WiSys is seeking a strategic partner interested in providing a route to market for the commercialization and use of this anthocyanin extraction system. There is also interest in partnering with a fruit processing company for the continued testing and scaling of this system.
WiSys is seeking a strategic partner skilled in the development and manufacturing of membranes used for the separation and/or detection of biologic molecules in solution. There is additional interest in a partner with the expertise to identify and test novel applications for these nanomembranes.
WiSys is seeking strategic partners interested in further developing this portable water quality measuring technology for application-specific or broader based commercialization.
WiSys is seeking strategic partners for field testing of this novel device, as well as for development for mass manufacturing, followed by marketing, sales, and distribution.
WiSys Technology Foundation is seeking a strategic partner with an industry player in the life science tools and reagents industry for the further development and commercialization of its novel monomeric fluorescent protein.
WiSys Technology Foundation is currently seeking a strategic industry partner to assist in the further development of its lead compound, A11, and related analogues providing a route to market for their use as novel skin whitening/lightening agents.The competitive advantage of these compounds over existing agents on the market is that they produce long-acting and reversible skin lightening with no toxicity.